首页> 外文OA文献 >PCV7 A Mixed Treatment Comparison (MTC) to Compare the Efficacy of Anti-Thrombotic Agents in the Prevention of Stroke and Systemic Embolism (SE) in Patients with Non-Valvular Atrial Fibrillation (NVAF)

【2h】

PCV7 A Mixed Treatment Comparison (MTC) to Compare the Efficacy of Anti-Thrombotic Agents in the Prevention of Stroke and Systemic Embolism (SE) in Patients with Non-Valvular Atrial Fibrillation (NVAF)

机译：PCV7混合治疗比较（MTC），用于比较抗栓剂在预防非瓣膜性房颤（NVAF）患者中风和全身性栓塞（SE）中的功效

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Edwards S.J.; Hamilton V.; Nherera L.; Trevor N.; Barton S.;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Response to Letter Regarding Article, "Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation: Validation of the R(2)CHADS(2) Index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study Cohorts" [J] . Piccini Jonathan P., Stevens Susanna R., Chang YuChiao, Circulation: An Official Journal of the American Heart Association . 2013,第11期

机译：对有关“非瓣膜性房颤患者中风和全身性栓塞的预测指标：肾功能不全：ROCKET AF（Rivaroxaban每日一次，口服，直接因素）中的R（2）CHADS（2）指数的验证的答复Xa抑制与维生素K拮抗剂在房颤预防卒中和栓塞试验中的比较以及ATRIA（房颤的抗凝和危险因素）研究队列”
2. Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment. [J] . Fox KA, Piccini JP, Wojdyla D, European Heart Journal: The Journal of the European Society of Cardiology . 2011,第19期

机译：非瓣膜性心房颤动和中度肾功能不全患者使用利伐沙班和华法林相比可预防中风和全身性栓塞。
3. Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment [J] . Keith A.A. Fox, Jonathan P. Piccini, Daniel Wojdyla, European Heart Journal . 2011,第19期

机译：非瓣膜性心房颤动和中度肾功能不全患者使用利伐沙班与华法林相比预防中风和全身性栓塞
4. Clinical Efficacies of Recombinant Human Brain Natriuretic Peptide in the Treatment of Patients with Heart Failure Due to Valvular and Non-Valvular Heart Disease [C] . Jing Bai, Yan Wang 2019 International Conference on Biology, Chemistry and Medical Engineering（ 2019年国际生物、化学和医学工程会议（ICBCME 2019）论文集 . -1

机译：重组人脑利钠肽在瓣膜和非瓣膜心脏病患者治疗心力衰竭患者中的临床疗效
5. Optimal Post-Procedural Therapy for Patients Ineligble for Treatment with Oral Anticoagulatiion Who Undergo Left Atrial Appendage Occlusion with the Watchman Device for Non-Valvular Atrial Fibrillation [D] . Whitehead, Kristen Marie. 2020

机译：用口腔抗凝血治疗患者患者的最佳过程治疗患者患有左心房阑尾闭塞与鹰刀用于非瓣膜心房颤动
6. Editors Choice: Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding safety and tolerability study of four doses of AZD0837 vs. vitamin K antagonists [O] . Gregory Y.H. Lip, Lars H. Rasmussen, S. Bertil Olsson, -1

机译：编辑推荐：口服直接凝血酶抑制剂AZD0837用于预防非瓣膜性房颤患者的中风和全身性栓塞：四种剂量AZD0837和维生素K拮抗剂的随机剂量指导安全性和耐受性研究
7. PCV15 A Mixed Treatment Comparison (Mtc) to Compare the Efficacy of Anti-Thrombotic Agents in Treatment and Secondary Prevention of Venous Thromboembolism (Vte) in Patients with Deep Vein Thrombosis (Dvt) [O] . Edwards SJ, van Velthoven MH, Crawford F 2015

机译：PCV15一项混合治疗比较（Mtc），用于比较抗血栓形成剂在深静脉血栓形成（Dvt）患者的静脉血栓栓塞（Vte）的治疗和二级预防中的功效

PCV7 A Mixed Treatment Comparison (MTC) to Compare the Efficacy of Anti-Thrombotic Agents in the Prevention of Stroke and Systemic Embolism (SE) in Patients with Non-Valvular Atrial Fibrillation (NVAF)

著录项

引文网络

相似文献

相关主题

期刊订阅